Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Immunoprecise Antibodies Ltd
IPA
Technology
Scientific & Technical Instruments
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem...
Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:IPA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
•••
Trevor Abes
X
Post by
Trevor Abes
on Dec 04, 2024 4:31pm
Buzz on the Bullboards: Tangible growth stocks
This week, Canada’s main stock index, the TSX, hit a record high thanks to gains in technology and bank stocks.
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 04, 2024 8:07am
New Press Release - IPA to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced it will be presenting at The Benchmark Company’s 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024,...
read article.
(22)
•••
wallpaper2
X
Comment by
wallpaper2
on Dec 04, 2024 5:09am
RE:IPA to Report Financial Results and Recent Business Highligh
They say they take questions but thats an Orchestrated circus. HC Wainwrights Mr Alphabet R is our analyst/rep and he thinks our lab is in Vancouver wtf
(274)
•••
whytestocks
X
Post by
whytestocks
on Dec 03, 2024 7:45pm
IPA to Report Financial Results and Recent Business Highligh
News; $IPA IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 on December 10, 2024The Company to host an earnings conference call via webcast IPA
...more
(3)
•••
AxeCap
X
Post by
AxeCap
on Dec 03, 2024 5:28pm
wagers on when they invest in crypto?
I mean why not right? Desperate times...
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 03, 2024 8:34am
New Press Release - IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 on December 10, 2024
The Company to host an earnings conference call via webcast IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced that it will host a conference call to discuss its quarterly results and recent...
read article.
(22)
•••
wallpaper2
X
Post by
wallpaper2
on Nov 26, 2024 10:55am
Heh Dart
I get one for you. LTNC. Smart. OTC listing.Just what you like...huge upside, pumpable, good volume etc. Not a Pot or Weed drink but a Hydrogen drink (all natural.) You can create any
...more
(22)
•••
wallpaper2
X
Comment by
wallpaper2
on Nov 26, 2024 10:24am
RE:RE:RE:Weeks
Not a pump and I haven't lost a dime. Don't touch it, just keep it on your watchlist.
(2306)
•••
dart321
X
Comment by
dart321
on Nov 25, 2024 1:29pm
RE:RE:Weeks
LOL, yup and far to deep for everyone else, my god man you lost almost everything over this pump give it up and move on, life is to short to dwell on bs pumps. We all make mistakes but you don't
...more
(22)
•••
wallpaper2
X
Comment by
wallpaper2
on Nov 25, 2024 8:28am
RE:Weeks
This stock is far too deep for your simple mind. Go back to your Molecule MLCL and try to get it over a penny lol
(2306)
•••
dart321
X
Post by
dart321
on Nov 21, 2024 5:57pm
Weeks
or is it days away from the pinl sheets? Or is it a total de-listing within days ot weeks? The pump is over wallyworld. How much did you drop?????
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 13, 2024 9:10am
New Press Release - $20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies
Innovative Antibodies Show Promise for Antibody-Drug Conjugate (ADC) Development, Paving the Way for Transformative Cancer Treatments ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), a leader in AI-driven medical innovation, is proud to announce a significant breakthrough in...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 04, 2024 8:09am
New Press Release - ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation
ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA),an AI-driven biotherapeutic research and technology company, announces the details of its upcoming TECHDAY event on Friday, November 15, 2024, from 9:00 a.m. to 12:30 p.m. EST in Cambridge, Massachusetts. This exclusive...
read article.
(2306)
•••
dart321
X
Comment by
dart321
on Nov 01, 2024 10:01pm
RE:RE:RE:Why haven't you read the Oct.2&10 posts here?
Hey wallyworld what ever happened to the big pumps. You know the ones where you said it was going to 30 or 40 bucks, Oh right the path has been there all along, did everyone get lost on the path? Did
...more
(2306)
•••
dart321
X
Comment by
dart321
on Oct 30, 2024 1:02pm
RE:RE:RE:Why haven't you read the Oct.2&10 posts here?
wallyworld, is it pink sheet time? It's like rats running away from a dumpster fire.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 28, 2024 7:31am
New Press Release - ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology
Rabbit B Cell Select® Platform Yields Novel Antibodies for Studying Age-Related Mitochondrial Dysfunction ImmunoPrecise Antibodies Ltd. ("IPA" or the "Company") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, announces its significant contribution to a groundbreaking...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Rig Count Soars as Utilization Surpasses Industry Averages